Literature DB >> 8764062

Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex.

F Kashanchi1, S N Khleif, J F Duvall, M R Sadaie, M F Radonovich, M Cho, M A Martin, S Y Chen, R Weinmann, J N Brady.   

Abstract

We have previously reported the direct physical interaction between the human immunodeficiency virus (HIV) type I Tat protein and the basal transcription factor TBP/TFIID. Affinity chromatography demonstrated that wild-type Tat, but not a transactivation mutant of Tat, was capable of depleting TBP/TFIID from cell extracts. These experiments represented the first demonstration of a basal transcription factor that binds, in an activation-dependent manner, to Tat. We now report that the Tat-TBP interaction can be detected in HIV type 1-infected cells. The domain of TBP interacting with Tat has been mapped from amino acids 163 to 196 by using deletion and site-specific mutants of TBP. This domain of TBP, which includes the HI and S2 domains, is distinct from the H2 binding site for other activator proteins, such as E1A. The interaction of Tat with TFIID regulates the binding of accessory proteins to TFIID. Tat stabilizes the interaction of TFIID with TFIIA in a gel shift assay. In addition, Tat competes for Dr1 interaction with TBP. Our results suggest that the basal transcription factor TBP/TFIID represents an important regulatory molecule in HIV transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764062      PMCID: PMC190508     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro.

Authors:  C A Bohan; F Kashanchi; B Ensoli; L Buonaguro; K A Boris-Lawrie; J N Brady
Journal:  Gene Expr       Date:  1992

2.  Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles.

Authors:  H Sato; J Orenstein; D Dimitrov; M Martin
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

3.  Electroporation of viral transactivator proteins into lymphocyte suspension cells.

Authors:  F Kashanchi; J F Duvall; J N Brady
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

4.  The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes.

Authors:  B Ohana; P A Moore; S M Ruben; C D Southgate; M R Green; C A Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

Review 5.  TBP, a universal eukaryotic transcription factor?

Authors:  N Hernandez
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

6.  The TATA-binding protein and associated factors are integral components of the RNA polymerase I transcription factor, SL1.

Authors:  L Comai; N Tanese; R Tjian
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

7.  Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription.

Authors:  J A Inostroza; F H Mermelstein; I Ha; W S Lane; D Reinberg
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

8.  The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB.

Authors:  G A Kassavetis; C A Joazeiro; M Pisano; E P Geiduschek; T Colbert; S Hahn; J A Blanco
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

9.  Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.

Authors:  L J Chang; E McNulty; M Martin
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Transcriptional activation by simian virus 40 large T antigen: interactions with multiple components of the transcription complex.

Authors:  M C Gruda; J M Zabolotny; J H Xiao; I Davidson; J C Alwine
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

View more
  19 in total

Review 1.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

2.  A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity.

Authors:  S Nekhai; R R Shukla; A Kumar
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme.

Authors:  T P Cujec; H Cho; E Maldonado; J Meyer; D Reinberg; B M Peterlin
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

4.  Tat-MyoD fused proteins, together with C2c12 conditioned medium, are able to induce equine adult mesenchimal stem cells towards the myogenic fate.

Authors:  Marco Patruno; Chiara Gomiero; Roberta Sacchetto; Ohad Topel; Alessandro Negro; Tiziana Martinello
Journal:  Vet Res Commun       Date:  2017-06-06       Impact factor: 2.459

5.  Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.

Authors:  Jennifer L Welch; Hussein Kaddour; Patrick M Schlievert; Jack T Stapleton; Chioma M Okeoma
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

6.  Transcription through the HIV-1 nucleosomes: effects of the PBAF complex in Tat activated transcription.

Authors:  Rebecca Easley; Lawrence Carpio; Luke Dannenberg; Soyun Choi; Dowser Alani; Rachel Van Duyne; Irene Guendel; Zachary Klase; Emmanuel Agbottah; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  Virology       Date:  2010-09-30       Impact factor: 3.616

7.  Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.

Authors:  F Kashanchi; E T Agbottah; C A Pise-Masison; R Mahieux; J Duvall; A Kumar; J N Brady
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription.

Authors:  Rachel Van Duyne; Irene Guendel; Elizabeth Jaworski; Gavin Sampey; Zachary Klase; Hao Chen; Chen Zeng; Dmytro Kovalskyy; Mahmoud H El Kouni; Benjamin Lepene; Alexis Patanarut; Sergei Nekhai; David H Price; Fatah Kashanchi
Journal:  J Mol Biol       Date:  2012-12-13       Impact factor: 5.469

9.  Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Authors:  Reem Berro; Kylene Kehn; Cynthia de la Fuente; Anne Pumfery; Richard Adair; John Wade; Anamaris M Colberg-Poley; John Hiscott; Fatah Kashanchi
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Effects of Tat proteins and Tat mutants of different human immunodeficiency virus type 1 clades on glial JC virus early and late gene transcription.

Authors:  Clayton A Wright; Jonas A Nance; Edward M Johnson
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.